|
|
| This section contains news about product launches and information on FDA approvals and clearances of drugs, devices and other products relevant to gastroenterology, endoscopy, colorectal surgery and general medicine. If you would like to feature a product in Gastroenterology & Endoscopy News’ FDA Update & Product News section, please Contact the editor. |
|
|
Ethicon Endo-Surgery Now Offers Two New Staplers For Open Surgery
ISSUE: AUGUST, 2010 Ethicon Endo-Surgery has two new surgical staplers designed to optimize compression during open surgery.
read more
|
Covidien Launches SILS Stitch Suturing Device For Laparoscopy
ISSUE: AUGUST, 2010 Covidien now offers the SILS Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures.
read more
|
FDA Clears New Addition to Covidien’s V-Loc Knotless Wound-Closure Line
ISSUE: AUGUST, 2010 The FDA has cleared the latest in Covidien’s line of absorbable wound-closure devices for knotless tissue repair, the V-Loc 90.
read more
|
FDA Warns of Rare Cases of Liver Injury With Xenical, Alli Weight-Loss Drugs
ISSUE: AUGUST, 2010 The FDA has issued a warning about rare reports of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli.
read more
|
FDA and NIH Launch Electronic Safety Reporting Portal
ISSUE: AUGUST, 2010 The FDA and the National Institutes of Health have launched a new Web site that, when fully developed, will provide a mechanism for reporting pre- and postmarket safety data to the federal government.
read more
|
EndoChoice Receives FDA Clearance for Bonastent Esophageal and Biliary Stents
ISSUE: AUGUST, 2010 EndoChoice, Inc. has received 510(k) clearance from the FDA to market its Bonastent Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions and Bonastent Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
read more
|
Xifaxan 550-mg Tablets Now Available in Pharmacies
ISSUE: JULY, 2010 Following its FDA approval for the treatment of hepatic encephalopathy in March, Salix Pharmaceuticals’ rifaximin (Xifaxan) 550-mg tablets are now available in pharmacies throughout the United States.
read more
|
Takeda Launches New Web Site To Help Patients With IBS Talk to Physicians
ISSUE: JULY, 2010 New tools are now available to help patients living with irritable bowel syndrome (IBS) describe their symptoms to a health care provider and establish a treatment plan at www.letstalkibs.com.
read more
|